Ascaris Lumbricoides Infection
7
1
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
43%
3 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
Cement flooRs AnD chiLd hEalth (CRADLE)
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases
Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura
Evaluating Impact of Improved Floors on Health
Impact of A. Lumbricoides on Pulmonary Aspergillosis Development